The United Laboratories Stock Net Asset
| ULIHFDelisted Stock | USD 1.09 0.00 0.00% |
The United Laboratories fundamentals help investors to digest information that contributes to United Laboratories' financial success or failures. It also enables traders to predict the movement of United Pink Sheet. The fundamental analysis module provides a way to measure United Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to United Laboratories pink sheet.
United |
The United Laboratories Company Net Asset Analysis
United Laboratories' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current United Laboratories Net Asset | 16.33 B |
Most of United Laboratories' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The United Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, The United Laboratories has a Net Asset of 16.33 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.
United Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses United Laboratories' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of United Laboratories could also be used in its relative valuation, which is a method of valuing United Laboratories by comparing valuation metrics of similar companies.United Laboratories is currently under evaluation in net asset category among its peers.
United Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0539 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 850.36 M | |||
| Shares Outstanding | 1.82 B | |||
| Shares Owned By Insiders | 50.35 % | |||
| Shares Owned By Institutions | 8.56 % | |||
| Price To Earning | 8.47 X | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 9.7 B | |||
| Gross Profit | 4.21 B | |||
| EBITDA | 1.26 B | |||
| Net Income | 988.1 M | |||
| Cash And Equivalents | 4.04 B | |||
| Cash Per Share | 2.22 X | |||
| Total Debt | 221.21 M | |||
| Debt To Equity | 0.22 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 5.36 X | |||
| Cash Flow From Operations | 1.54 B | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 13.6 K | |||
| Beta | 0.3 | |||
| Market Capitalization | 1.29 B | |||
| Total Asset | 16.33 B | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 16.33 B | |||
| Last Dividend Paid | 0.13 |
About United Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The United Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of United Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The United Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in United Pink Sheet
If you are still planning to invest in The United Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the United Laboratories' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |